Profund Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Sell |
10,283
-356
| -3% | -$11.3K | 0.01% | 646 |
|
|
2025
Q1 | $353K | Sell |
10,639
-440
| -4% | -$14.6K | 0.02% | 597 |
|
|
2024
Q4 | $381K | Buy |
11,079
+4,651
| +72% | +$160K | 0.01% | 654 |
|
|
2024
Q3 | $257K | Sell |
6,428
-1,129
| -15% | -$45.2K | 0.01% | 895 |
|
|
2024
Q2 | $228K | Buy |
7,557
+758
| +11% | +$22.9K | 0.01% | 909 |
|
|
2024
Q1 | $228K | Sell |
6,799
-4,718
| -41% | -$158K | 0.01% | 1009 |
|
|
2023
Q4 | $372K | Buy |
11,517
+3,187
| +38% | +$103K | 0.02% | 673 |
|
|
2023
Q3 | $273K | Sell |
8,330
-1,968
| -19% | -$64.5K | 0.02% | 709 |
|
|
2023
Q2 | $362K | Buy |
10,298
+287
| +3% | +$10.1K | 0.02% | 622 |
|
|
2023
Q1 | $327K | Buy |
10,011
+6,198
| +163% | +$202K | 0.02% | 676 |
|
|
2022
Q4 | $210K | Buy |
+3,813
| New | +$210K | 0.01% | 884 |
|